Bioassay-guided fractionation of the methanol extract from the root of Sophora flavescens led to the isolation of eight known prenylated flavonoids responsible for the vasorelaxation activity in porcine coronary arteries. Among them, kushenol N and 5-methylsophoraflavanone B strongly induced the relaxation of porcine coronary arteries with respective ED 50 values of 8.6 and 12.4 M. This activity and the results of a highperformance liquid chromatographic analysis suggest that kushenol N and 5-methylsophoraflavanone B could be active markers in the S. flavescens extract for vasorelaxation activity.
Bioassay-guided fractionation of the methanol extract from the root of Sophora flavescens led to the isolation of eight known prenylated flavonoids responsible for the vasorelaxation activity in porcine coronary arteries. Among them, kushenol N and 5-methylsophoraflavanone B strongly induced the relaxation of porcine coronary arteries with respective ED 50 values of 8.6 and 12.4 M. This activity and the results of a highperformance liquid chromatographic analysis suggest that kushenol N and 5-methylsophoraflavanone B could be active markers in the S. flavescens extract for vasorelaxation activity.
Key words: vasorelaxation activity; Sophora flavescens; prenylated flavonoid; kushenol N; 5-methylsophoraflavanone B Cardiovascular diseases are the major cause of death in the developed countries. Dysfunction of the vascular endothelium is a hallmark of cardiovascular diseases and is characterized by multiple factors, including impaired vasodilation, tissue perfusion, hemostasis, and thrombosis. 1) Substantial evidence suggests that plant-derived flavonoids are associated with decreased global mortality due to a reduced number of cardiovascular diseases and might be involved in protecting against cardiovascular risk. 2, 3) During our previous research work aimed at discovering new cardiovascular protective agents, about three hundred different medicinal plants used in oriental medicine were screened by evaluating their vasorelaxation activity of the solvent extract. 4) Among them, the extract from the roots of Sophora flavescens Ait. (Leguminosae) was found to exhibit potent vasorelaxation activity in the porcine coronary artery rings. Bioassay-guided fractionation of this plant extract, using an assay that evaluated the relaxation of porcine coronary arteries preconstricted with the thromboxane mimetic, U46619 (1-60 nM), to about 80% of the maximal constriction, 5) led to the isolation of two active prenylated flavonoids. We report in this paper the isolation of the active principles from an S. flavescens root extract and their ex vivo vasorelaxation activities.
The methanolic extract of S. flavescens was suspended in H 2 O and successively partitioned with methylene chloride and n-butanol. The methylene chloride-soluble material was active in a dose-dependent manner (Fig. 1) . Eight prenylated flavonoids in the bioactive methylene chloride fraction (2 g) were purified by semi-preparative HPLC with an acetonitrile-H 2 O gradient (35:65 to 70:30 in 60 min, 70:30 in 10 min, 10 mL/min, 210 nm).
6) The HPLC chromatogram of S. flavescens ( Fig. 2A) showed kurarinone (4) and sophoraflavanone G (6) to be the major components in the S. flavescens extract. The chemical structures of these isolated compounds were elucidated to be 3,7,4 0 -trihydroxy-5-methoxy-8-prenylflavanone (1, 24.8 mg), 7, 8) 5-methylsophoraflavanone B (2, 38.4 mg), 7) kushenol N (3, 47.3 mg), 8) kurarinone (4, 154.5 mg), 8, 9) 2 0 -methoxykurarinone (5, 22.0 mg), 9) sophoraflavanone G (6, 104.0 mg), [8] [9] [10] leachianone A (7, 31.6 mg), 9, 10) and kuraridin (8, 34.7 mg) 8) (Fig. 2) by Porcine coronary artery rings with the endothelium were preconstricted with the thromboxane mimetic, U46619 (1 to 60 nM) to about 80% of the maximal constriction, and the integrity of the endothelium was checked with bradykinin (0.3 mM). After washing out and a 30-min equilibration period, the rings were again constricted with U46619 before a concentration-relaxation curve was constructed for the total extract or each fraction. Each result is shown as the mean AE SEM of 4 to 6 different experiments. A statistical evaluation was performed with Student's t test for paired data or by ANOVA with subsequent Fischer's protected least significant difference test where appropriate.
ÃÃ and ÃÃÃ respectively represent p < 0:05 and 0.01 compared with the control (0.1% DMSO).
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The vasorelaxation effect of each prenylated flavonoid was measured by an assay to evaluate the relaxation of porcine coronary arteries as previously described.
11) The very well-known vasorelaxant polyphenols, epigallocatechin gallate (EGCG), was used as a positive control. Among those compounds, kushenol N (3) and 5-methylsophoraflavanone B (2) exhibited a potent vasorelaxation effect on porcine coronary arteries with respective ED 50 values of 8:6 AE 4:1 and 12:4 AE 7:5 mM (Fig. 2B) . These effects were more potent than that of epigallocatechin gallate (EGCG, ED 50 47:1 mM AE 10:2, Fig. 3 ).
11) 3,7,4 0 -Trihydroxy-5-methoxy-8-prenylflavanone (1) showed 100% relaxation at 100 mM, while epigallocatechin gallate exhibited 80% relaxation at the same concentration (Fig. 3) . In addition, other prenylated flavonoids showed significant vasorelaxation effects on porcine coronary arteries with EC 50 values ranging from 30 to 60 mM, except for kuraridin (8) (more than 100 mM).
Several comparative studies of the vasorelaxation activity of synthetic prenylated flavonoids have previously been reported. [12] [13] [14] The presence of a prenyl group in the A ring and hydroxyl groups in the B ring were important for the activities of prenylated flavonoids. 12, 14) A subsequent study of the structure-activity relationship for prenylated chalcones has indicated that the substitution pattern and number of hydroxyl groups in the B-ring to also be crucial for vasorelaxation activity. 13) All seven tested flavanones (1-7) with 8-prenyl or 8-lavandulyl substituents exhibited significant vasorelaxation activity in our study. It was not possible to derive accurate structure-activity information due to the limited set of 8-prenylated flavanones. However, activity data indicated that the vasorelaxation activity was associated with the presence of a substituent at C-3 and by its configuration (2 > 1; 3 > 4, Fig. 2B ) in the 8-prenylated flavanones.
Kushenol N (3) and 5-methylsophoraflavanone B (2) were also major compounds that exhibited stronger vasorelaxant activities than other compounds (Fig. 2) . These two compounds could be marker for standardization of crude extract from roots of S. flavescens for vasorelaxation effect.
An S. flavescens extract has recently induced relaxation of phenylephrine-precontracted aortic rings, its vasorelaxation mechanism involving the release of nitric oxide from the endothelium, activation of soluble guanylyl cyclase-cGMP signaling in the vascular smooth muscle, and inhibition of Ca 2þ entry via blockage of the L-type Ca 2þ channels through cGMP signaling. 15) Taken together, the present findings indicate that the vasorelaxation effect of the S. flavescens extract was mediated, at least in part, by 8-prenylated flavonoids. They further suggest that 8-prenylflavonoids would be a promising structural template for new cardiovascular protective agents of natural origin. Results are shown as the mean AE SEM of 4 to 6 different experiments. A statistical evaluation was performed by Student's t test for paired data or ANOVA and subsequent Fischer's protected least significant difference test where appropriate.
